Deep deletion of ETV6, a transcription-regulating gene, has been previously implicated in leukemias and may play a role in oncogenesis, treatment response, and outcome in pediatric ALL patients [44,45,46,47]. This evidence concerns the gene ETV6 and acute lymphoblastic leukemia.